Rab11A Protein (Ras Related Protein Rab 11A) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Name | RAB11A (Ras-Related Protein Rab-11A) |
|---|
| Gene | RAB11A |
|---|
| UniProt ID | P62491 |
|---|
| PDB ID | 1OIX, 1YW3, 4C0P |
|---|
| Molecular Weight | 24.4 kDa |
|---|
| Subcellular Localization | Recycling Endosome, Synaptic Vesicles |
|---|
| Protein Family | Rab GTPase Family |
|---|
RAB11A is a small GTPase that regulates recycling endosome trafficking, essential for synaptic plasticity, neurotransmitter receptor recycling, and cellular signaling. It controls the return of receptors and vesicles to the plasma membrane.
RAB11A is a 216-amino acid GTPase:
- Switch I/II regions for GTP binding
- C-terminal geranylgeranylation for membrane association
- Multiple effector binding sites
- Receptor recycling: Controls AMPA, NMDA, GABA receptor return to membrane[1]
- Synaptic plasticity: Essential for activity-dependent modifications
- Neurotrophin trafficking: Regulates BDNF/TrkB recycling
- Membrane protein turnover: Participates in endocytic recycling
- Activity-dependent plasticity: RAB11-mediated recycling required for LTP
- Synaptic vesicle biogenesis: Controls synaptic vesicle protein trafficking
- Dendritic spine morphology: Regulates spine development
- Impaired recycling endosome function in AD neurons[2]
- RAB11 regulates APP trafficking and processing
- Synaptic receptor recycling deficits
- Contributes to cognitive decline
- Dopamine transporter (DAT) trafficking requires RAB11[3]
- Alpha-synuclein affects RAB11-dependent recycling
- LRRK2 mutations alter endosomal function
- Park M, et al. (2004). RAB11 regulates synaptic plasticity. Neuron. PMID:15541309
- Wang X, et al. (2018). RAB11 in neurodegenerative disease. Mol Neurobiol. PMID:29134556
- Bardi G, et al. (2021). RAB11 and synaptic function. J Neurosci Res. PMID:33544923
The study of Rab11A Protein (Ras Related Protein Rab 11A) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Wang Y, et al. "RAB11A in AMPA receptor recycling and synaptic plasticity." J Neurosci. 2021;41(8):1621-1634. PMID:33402415
- Liu J, et al. "Recycling endosomes in dendritic spine formation." Nat Neurosci. 2020;23(10):1209-1220. PMID:32801339
- Umeda T, et al. "RAB11A-mediated trafficking in tauopathies." Acta Neuropathol Commun. 2019;7(1):73. PMID:31118078
- Kienle M, et al. "RAB11 in neuronal protein sorting." Cell Mol Life Sci. 2018;75(10):1775-1791. PMID:29327071
- Nakagawa O, et al. "RAB11A dysfunction in Parkinsonian syndromes." Parkinsonism Relat Disord. 2017;42:57-62. PMID:28457629
RAB11A represents a potential therapeutic target for neurodegenerative diseases:
- Small molecule modulators: Developing compounds that enhance RAB11 function
- Gene therapy approaches: Viral vector delivery of RAB11
- Protein-protein interaction inhibitors: Targeting RAB11 effectors
- Understanding RAB11 dysfunction in specific disease contexts
- Developing biomarkers for recycling endosome function
- Preclinical validation in animal models
RAB11A expression and function may serve as biomarkers:
- Diagnostic: Recycling endosome function in patient cells
- Progression: Disease severity correlation
- Therapeutic response: Treatment efficacy marker
Key areas for future research:
- RAB11 isoform-specific functions in neurons
- Post-translational modifications and their effects
- Effector protein interactions in disease
- Biomarker development for neurodegenerative diseases
- Therapeutic modulation of RAB11 function
- Personalized medicine approaches based on RAB11 genetics